Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isobaric Ropivacaine 15 mg Versus Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Geriatric Patients Undergoing Total Knee Arthroplasty

NCT02764723 is registered in ClinicalTrials.gov with Mohamed Sayed Mohamed Abbas as lead sponsor.

NCT NCT02764723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02764723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isobaric Ropivacaine 15 mg Versus Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Geriatric Patients Undergoing Total Knee Arthroplasty
Lead sponsor
Mohamed Sayed Mohamed Abbas
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
December 31, 2015
Enrollment
52 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

spinal anesthesia, total knee arthroplasty in geriatric patients